Related Experiment Video
Updated: May 26, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
[Systemic amyloidosis in inflammatory bowel disease].
Juan E Naves1, Eugeni Domènech
1Unidad de Gastroenterología-Enfermedades Inflamatorias Intestinales, Servicio de Aparato Digestivo, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, España.
Systemic amyloidosis, a protein buildup disease, can arise from chronic inflammation like Inflammatory Bowel Disease (IBD). This review examines amyloidosis prevalence, risk factors, and outcomes in IBD patients.
Area of Science:
- Immunology
- Gastroenterology
- Pathology
Context:
- Systemic amyloidosis involves abnormal protein accumulation in organs, impairing function.
- Secondary amyloidosis is linked to chronic inflammatory conditions, including Inflammatory Bowel Disease (IBD).
- The prevalence, risk factors, and outcomes of amyloidosis in IBD patients are not well-understood.
Purpose:
- To review current data on secondary amyloidosis in Inflammatory Bowel Disease (IBD).
- To focus on the prevalence, risk factors, clinical presentation, and therapeutic strategies for amyloidosis in IBD.
- To highlight the association between Crohn's disease and amyloidosis, particularly in extensive, long-standing cases.
Summary:
- Amyloidosis is a complication of chronic inflammation, with IBD being a potential cause.
- Studies suggest higher prevalence in Crohn's disease versus ulcerative colitis, associated with severe disease patterns.
- This review synthesizes existing knowledge on secondary amyloidosis and IBD.
Impact:
- Enhances understanding of a rare but serious complication in IBD patients.
- Provides a foundation for future research into risk stratification and management.
- Aims to improve clinical awareness and patient outcomes for amyloidosis in IBD.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

